• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 0
      Cystic fibrosis triple therapy does not eliminate bacterial infection predisposal in vitro - 1 year(s) ago

      It is known that persons with cystic fibrosis are more susceptible to infections; however, the impact of elexacaftor/tezacaftor/ivacaftor therapy on this susceptibility has not been well studied yet. In a study published in American Journal of Respiratory Cell and Molecular Biology, researchers explored whether triple therapy stopped docking stations, a mechanism tied to bacterial infections,

      Source: www.healio.com
      Categories: General Medicine News, Pulmonology
      Tweet Tweets with this article
      • Profile photo of 	HealioPulm
        HealioPulm

        Researchers explored whether triple therapy stopped docking stations, a mechanism tied to bacterial #infections, from forming in those with cystic fibrosis. @AJRCMB Healio spoke with Marc Chanson, PhD, and Mehdi Badaoui, PhD, @UNIGEnews, to learn more🔽 https://t.co/0hMo0vQyGJ

    • Mashup Score: 0
      Cystic fibrosis triple therapy does not eliminate bacterial infection predisposal in vitro - 1 year(s) ago

      It is known that persons with cystic fibrosis are more susceptible to infections; however, the impact of elexacaftor/tezacaftor/ivacaftor therapy on this susceptibility has not been well studied yet. In a study published in American Journal of Respiratory Cell and Molecular Biology, researchers explored whether triple therapy stopped docking stations, a mechanism tied to bacterial infections,

      Source: www.healio.com
      Categories: General Medicine News, Pulmonology
      Tweet Tweets with this article
      • Profile photo of 	HealioPulm
        HealioPulm

        Researchers explored whether triple therapy stopped docking stations, a mechanism tied to bacterial #infections, from forming in those with cystic fibrosis. @AJRCMB Healio spoke with Marc Chanson, PhD, and Mehdi Badaoui, PhD, @UNIGEnews, to learn more🔽 https://t.co/0hMo0vQyGJ

    • Mashup Score: 1
      Ripretinib inhibits HIV-1 transcription through modulation of PI3K-AKT-mTOR - 1 year(s) ago

      Acta Pharmacologica Sinica – Ripretinib inhibits HIV-1 transcription through modulation of PI3K-AKT-mTOR

      Source: www.nature.com
      Categories: General Medicine News, Infectious Disease
      Tweet Tweets with this article
      • Profile photo of 	infdisease_news
        infdisease_news

        Researchers discovered ripretinib being an LPA candidate, which was ✔️ validated and observed to hinder proviral activation in cell models harboring latent #infections, as well as CD4+ T cells 🧫 derived from infected patients. 🔗 https://t.co/mNsqc4MnM1 https://t.co/2KDB0rf6oc

    • Mashup Score: 1
      Q&A: Inhaled mRNA therapy may help combat seasonal, emerging respiratory viruses - 2 year(s) ago

      The U.K. Medicines and Healthcare products Regulatory Agency recently approved a phase 1 study that will test an inhaled mRNA-based drug as a treatment and prophylaxis of respiratory viral infections, according to a press release.In this trial, healthy participants will receive ETH47 (Ethris) through inhalation or nasal spray.

      Source: www.healio.com
      Categories: General Medicine News, Pulmonology
      Tweet Tweets with this article
      • Profile photo of 	HealioPulm
        HealioPulm

        An inhaled mRNA-based drug, ETH47 (Ethris), will be tested as a treatment and prophylaxis for respiratory viral #infections🤧, and Healio spoke with Carsten Rudolph, PhD, CEO of @ethris_mRNA, to learn more. Read more⬇️ https://t.co/LoimgemWZa

    • Mashup Score: 1
      Q&A: Inhaled mRNA therapy may help combat seasonal, emerging respiratory viruses - 2 year(s) ago

      The U.K. Medicines and Healthcare products Regulatory Agency recently approved a phase 1 study that will test an inhaled mRNA-based drug as a treatment and prophylaxis of respiratory viral infections, according to a press release.In this trial, healthy participants will receive ETH47 (Ethris) through inhalation or nasal spray.

      Source: www.healio.com
      Categories: General Medicine News, Pulmonology
      Tweet Tweets with this article
      • Profile photo of 	HealioPulm
        HealioPulm

        An inhaled mRNA-based drug, ETH47 (Ethris), will be tested as a treatment and prophylaxis for respiratory viral #infections🤧, and Healio spoke with Carsten Rudolph, PhD, CEO of @ethris_mRNA, to learn more. Read more⬇️ https://t.co/LoimgemWZa

    • Mashup Score: 6
      Invasive fungal infection in ANCA-associated vasculitis: Between the Devil and Deep blue sea. Case series and review of the literature - 2 year(s) ago

      Source: link.springer.com
      Categories: Latest Headlines, Rheumatology
      Tweet Tweets with this article
      • Profile photo of 	ClinRheumatol
        ClinRheumatol

        📌Patients with #ANCAvasculitis are prone to invasive #fungal #infections (IFI) due to immunosuppression, tissue necrosis, and iron availability in the necrotic tissues 📌Differentiating disease activity from IFI is difficult 📌Poor prognosis 👉https://t.co/JCPicJbQu7 https://t.co/tzF0SjOGL7

    • Mashup Score: 1
      MyD88 signaling by neurons induces chemokines that recruit protective leukocytes to the virus-infected CNS - 2 year(s) ago

      During viral CNS infection, MyD88 signaling in infected neurons orchestrates recruitment of protective peripheral immune cells.

      Source: www.science.org
      Categories: Allergy-Immunology, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	SciImmunology
        SciImmunology

        A 2021 study from @stanfordimmuno @VAPaloAlto in mice and human #Tcells yielded a better understanding of why older individuals have a harder time fighting off #infections and provided a potential target for anti-aging treatments. 📄: https://t.co/m22Rs2DaoO #WeekendReads https://t.co/gIKqvFMboz

    • Mashup Score: 0
      Infections, Rather Than Inflammation or Autoimmune Disease, Associated With Dementia Development - 2 year(s) ago

      A nationwide study conducted in Denmark found an association between dementia incidence and previous exposure to infection, but the potential impacts of systemic inflammation or autoimmune diseases on dementia incidence were not as clear.

      Source: www.ajmc.com
      Categories: General Medicine Journals and Societies, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	AJMC_Journal
        AJMC_Journal

        Intriguing connections between #dementia incidence and prior exposure to #infections were revealed according to a study from Denmark. However, the influence of #SystemicInflammation or #AutoimmuneDiseases on #dementia incidence remained complex. https://t.co/iFnoCAUXNK https://t.co/b1vMamHS9p

    • Mashup Score: 0
      Clinical Features, Immunological Characteristics, and Treatment Outcomes of Campylobacter spp. Infections in Patients With Common Variable Immunodeficiency - 2 year(s) ago

      Campylobacter infection usually causes a self-limited clinical illness lasting 5 to 7 days, resolving without antimicrobial treatment in immunocompetent subjects. However, an inadequate immune response can lead to a prolonged and severe disease requiring antibiotics and more aggressive therapeutic approaches.

      Source: www.jaci-inpractice.org
      Categories: Allergy-Immunology, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	JACIInPractice
        JACIInPractice

        In Press! #Clinical Features, #Immunological Characteristics, and #Treatment #Outcomes of #Campylobacter spp. #Infections in #Patients With Common #Variable #Immunodeficiency https://t.co/P0gSBdUDog https://t.co/GfE6a5Azuv

    • Mashup Score: 0
      Mortality in Culture-Negative Sepsis Not Linked to Early Discontinuation of Antibiotics - 2 year(s) ago

      Early discontinuation of antibiotics was not significantly associated with increased mortality risk among patients with culture-negative severe sepsis.

      Source: Infectious Disease Advisor
      Categories: Infectious Disease, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	InfectDiseaseAd
        InfectDiseaseAd

        Early discontinuation of #antibiotics among patients with culture-negative severe #infections and sepsis is not associated with increased risk of #mortality, according to study results. https://t.co/dsUtP5mdnc

    Load More
    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings